Mervin Pieterse

Leiden University Medical Center

Papers

1

Total Citations

46

H-Index

1

About

Mervin Pieterse is a pioneering figure in the field of clinical proteomics, with a sharp focus on translating protein mass spectrometry (MS) from a research tool into a precision diagnostic powerhouse. His major contribution is a compelling, forward-looking vision: that quantitative protein MS tests are uniquely positioned to address unmet clinical needs. In his landmark 2021 paper, "The Time Has Come for Quantitative Protein Mass Spectrometry Tests That Target Unmet Clinical Needs," which has garnered 46 citations, Pieterse argues that unlike indirect immunoassays, MS offers direct, multiplexed quantification and the ability to identify distinct proteoforms—a critical advantage for accurate diagnostics. This work serves as a rallying cry for the field, challenging the status quo and highlighting the technology's readiness for routine clinical deployment. Pieterse’s impact lies in bridging the gap between analytical capability and clinical application, inspiring researchers and clinicians to adopt MS-based tests for more precise, reliable, and comprehensive patient care. His advocacy is shaping the next generation of diagnostic strategies.

Research Focus

Key Achievements

1
H-Index
1
Papers
46
Total Citations
46
Avg Citations/Paper
🏆 Most Cited Paper
The Time Has Come for Quantitative Protein Mass Spectrometry Tests That Target Unmet Clinical Needs
46 citations · 2021
📈 Most Prolific Year: 2021 (1 Papers)
🤝 Key Collaborators: 5
🏛 Institutions: Leiden University Medical Center

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 15 days ago